Lates News

According to Every AI Quick News, Sinodata Securities published a research report on January 16th, giving a "buy" rating to Shanwaishan (688410.SH). The rating reasons mainly include: 1) China's hemodialysis equipment market is expected to exceed 50 billion yuan by 2030, with potential demand growth driven by policies such as the construction of medical consortia, benefiting Shanwaishan's domestic hemodialysis machine as a leader in import substitution; 2) Shanwaishan has a full product line layout in the field of blood purification "equipment-consumables", focusing on technology to establish product strength advantage; 3) Long-term development: deepening "research and innovation + global layout", accelerating towards becoming an international leader in blood purification. (Daily Economic News)